About Lokavant
Lokavant is a company based in New York (United States) founded in 2019 by Rohit Nambisan. Lokavant has raised $29 million across 2 funding rounds from investors including Roivant Sciences, Mitsui & Co and Edison Partners. Lokavant offers products and services including Spectrum. Lokavant operates in a competitive market with competitors including eClinical Solutions, Datacubed, JNPMEDI, SolveBio and IgniteData, among others.
- Headquarter New York, United States
- Founders Rohit Nambisan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lokavant, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$29 M (USD)
in 2 rounds
-
Latest Funding Round
$8 M (USD), Series A
Oct 03, 2023
-
Investors
Roivant Sciences
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lokavant
Lokavant offers a comprehensive portfolio of products and services, including Spectrum.
Uses AI for rapid clinical trial predictions and optimization.
People of Lokavant
Unlock access to complete
Unlock access to complete
Leadership Team
6 people
Product Management Team
2 people
Software Development Team
1 people
Advisor Team
1 people
Unlock access to complete
Funding Insights of Lokavant
Lokavant has successfully raised a total of $29M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lokavant
Lokavant has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Roivant Sciences, Mitsui & Co and Edison Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of a growth equity firm for adaptive and personalized plans
|
Locked | Locked | Locked | |
|
Traditional conglomerate services are provided across multiple sectors by Mitsui.
|
Locked | Locked | Locked | |
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
Locked | Locked | Locked |
Investor details for Lokavant
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lokavant
Investment portfolio details for Lokavant
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lokavant
Detailed financials for Lokavant
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lokavant Comparisons
Peer comparison for Lokavant
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lokavant
Lokavant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eClinical Solutions, Datacubed, JNPMEDI, SolveBio and IgniteData, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based software solutions for clinical data management are provided.
|
|
| Locked | Locked | Locked |
Provider of solutions for patient engagement and data management in clinical trails
|
|
| Locked | Locked | Locked |
Cloud-based clinical trial data management solutions are provided.
|
|
| Locked | Locked | Locked |
Genomic data analytics platform is provided for precision medicine.
|
|
| Locked | Locked | Locked |
Patient data is transformed for clinical trials via archer technology.
|
Detailed competitors of Lokavant
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lokavant
Complete news archive for Lokavant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lokavant
Lokavant was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Lokavant is headquartered in New York, United States. It is registered at New York, New York, United States.
Rohit Nambisan is the current CEO of Lokavant. They have also founded this company.
Lokavant is a funded company, having raised a total of $29M across 2 funding rounds to date.
Lokavant was founded in 2019 in New York, United States, and operates in the clinical trials sector. A platform is offered to Contract Research Organizations for integrating and analyzing clinical trial data. Real-time visualizations and risk alerts are generated through this system. Machine learning models are employed to predict trial risks and evaluate mitigation strategy impacts, with recommendations provided for risk management.
Lokavant's top competitors include eClinical Solutions, JNPMEDI and IgniteData.
Lokavant offers Spectrum.
Lokavant has 3 investors. Key investors include Roivant Sciences, Mitsui & Co, and Edison Partners.